Gregory John Carven Ph.D.
Net Worth

Last updated:

What is Gregory John Carven Ph.D. net worth?

The estimated net worth of Dr. Gregory John Carven Ph.D. is at least $10,234,562 as of 27 Jan 2021. He owns shares worth $1,005,588 as insider, has earned $7,023,654 from insider trading and has received compensation worth at least $2,205,320 in Scholar Rock Holding Corporation.

What is the salary of Gregory John Carven Ph.D.?

Dr. Gregory John Carven Ph.D. salary is $551,330 per year as Chief Scientific Officer in Scholar Rock Holding Corporation.

How old is Gregory John Carven Ph.D.?

Dr. Gregory John Carven Ph.D. is 49 years old, born in 1976.

What stocks does Gregory John Carven Ph.D. currently own?

As insider, Dr. Gregory John Carven Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Scholar Rock Holding Corporation (SRRK) Chief Scientific Officer 32,734 $30.72 $1,005,588

What does Scholar Rock Holding Corporation do?

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, and fibrosis. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.

SRRK logo
SRRK
Scholar Rock Holding Corporation
$30.72

Gregory John Carven Ph.D. insider trading

Scholar Rock Holding Corporation

Dr. Gregory John Carven Ph.D. has made 5 insider trades in 2021, according to the Form 4 filled with the SEC. Most recently he sold 38,200 units of SRRK stock on 27 Jan 2021.

The largest trade he's ever made was exercising 40,381 units of SRRK stock on 26 Jan 2021. As of 27 Jan 2021 he still owns at least 32,734 units of SRRK stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 38,200 N/A N/A
Option
Stock Option (Right to Buy) 6,619 N/A N/A
Option
Common Stock 6,619 N/A N/A
Sale
Common Stock 38,200 $56.79 $2,169,454
Sale
Common Stock 40,381 $60.11 $2,427,100
Sale
Common Stock 40,381 $60.11 $2,427,100
Option
Stock Option (Right to Buy) 30,900 N/A N/A
Sale
Common Stock 40,381 N/A N/A
Option
Stock Option (Right to Buy) 30,900 $11.63 $359,274
Option
Common Stock 30,900 $11.63 $359,274
Option
Common Stock 30,900 N/A N/A

Scholar Rock Holding key executives

Scholar Rock Holding Corporation executives and other stock owners filed with the SEC:

  • Dr. Gregory John Carven Ph.D. (49) Chief Scientific Officer
  • Dr. Nagesh K. Mahanthappa MBA, Ph.D. (60) Interim Chief Executive Officer & Director
  • Mr. Edward H. Myles M.B.A., MBA (53) Chief Financial Officer & Head of Bus. Operations